{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:08:06Z","timestamp":1791223686775,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T00:00:00Z","timestamp":1444003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/nm.3947","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T16:19:55Z","timestamp":1444061995000},"page":"1344-1349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":344,"title":["Loss of BAP1 function leads to EZH2-dependent transformation"],"prefix":"10.1038","volume":"21","author":[{"given":"Lindsay M","family":"LaFave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"B\u00e9guelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Koche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Teater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Chramiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Papalexi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Hricik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Konstantinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Micol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma H","family":"Doud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V","family":"Krivtsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rock","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Khodos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouathek","family":"Ouerfelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1699-2046","authenticated-orcid":false,"given":"Prasad S","family":"Adusumilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil L","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Keilhack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross L","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"key":"BFnm3947_CR1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/leu.2011.58","volume":"25","author":"O Abdel-Wahab","year":"2011","unstructured":"Abdel-Wahab, O. et al. Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms. Leukemia 25, 1200\u20131202 (2011).","journal-title":"Leukemia"},{"key":"BFnm3947_CR2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","volume":"145","author":"V Gelsi-Boyer","year":"2009","unstructured":"Gelsi-Boyer, V. et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br. J. Haematol. 145, 788\u2013800 (2009).","journal-title":"Br. J. Haematol."},{"key":"BFnm3947_CR3","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","volume":"364","author":"R Bejar","year":"2011","unstructured":"Bejar, R. et al. Clinical effect of point mutations in myelodysplastic syndromes. N. Engl. J. Med. 364, 2496\u20132506 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3947_CR4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott, M. et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat. Genet. 43, 668\u2013672 (2011).","journal-title":"Nat. Genet."},{"key":"BFnm3947_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pe\u00f1a-Llopis","year":"2012","unstructured":"Pe\u00f1a-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44, 751\u2013759 (2012).","journal-title":"Nat. Genet."},{"key":"BFnm3947_CR6","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J.W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20131413 (2010).","journal-title":"Science"},{"key":"BFnm3947_CR7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","volume":"465","author":"JC Scheuermann","year":"2010","unstructured":"Scheuermann, J.C. et al. Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB. Nature 465, 243\u2013247 (2010).","journal-title":"Nature"},{"key":"BFnm3947_CR8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey, A. et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337, 1541\u20131546 (2012).","journal-title":"Science"},{"key":"BFnm3947_CR9","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20131141","volume":"210","author":"O Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab, O. et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J. Exp. Med. 210, 2641\u20132659 (2013).","journal-title":"J. Exp. Med."},{"key":"BFnm3947_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","volume":"22","author":"O Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab, O. et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 22, 180\u2013193 (2012).","journal-title":"Cancer Cell"},{"key":"BFnm3947_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W B\u00e9guelin","year":"2013","unstructured":"B\u00e9guelin, W. et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23, 677\u2013692 (2013).","journal-title":"Cancer Cell"},{"key":"BFnm3947_CR12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","volume":"4","author":"IH Su","year":"2003","unstructured":"Su, I.H. et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4, 124\u2013131 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnm3947_CR13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/acsmedchemlett.5b00037","volume":"6","author":"JE Campbell","year":"2015","unstructured":"Campbell, J.E. et al. EPZ011989, a potent, orally available EZH2 inhibitor with robust in vivo activity. ACS Med. Chem. Lett. 6, 491\u2013495 (2015).","journal-title":"ACS Med. Chem. Lett."},{"key":"BFnm3947_CR14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1097-2765(02)00548-8","volume":"9","author":"K Nishioka","year":"2002","unstructured":"Nishioka, K. et al. PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol. Cell 9, 1201\u20131213 (2002).","journal-title":"Mol. Cell"},{"key":"BFnm3947_CR15","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1021\/cb500515r","volume":"9","author":"G Blum","year":"2014","unstructured":"Blum, G. et al. Small-molecule inhibitors of SETD8 with cellular activity. ACS Chem. Biol. 9, 2471\u20132478 (2014).","journal-title":"ACS Chem. Biol."},{"key":"BFnm3947_CR16","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/nar\/gkp086","volume":"37","author":"Y Guo","year":"2009","unstructured":"Guo, Y. et al. Methylation-state-specific recognition of histones by the MBT repeat protein L3MBTL2. Nucleic Acids Res. 37, 2204\u20132210 (2009).","journal-title":"Nucleic Acids Res."},{"key":"BFnm3947_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.stem.2012.06.002","volume":"11","author":"J Qin","year":"2012","unstructured":"Qin, J. et al. The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early development. Cell Stem Cell 11, 319\u2013332 (2012).","journal-title":"Cell Stem Cell"},{"key":"BFnm3947_CR18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.molcel.2011.04.004","volume":"42","author":"P Trojer","year":"2011","unstructured":"Trojer, P. et al. L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure. Mol. Cell 42, 438\u2013450 (2011).","journal-title":"Mol. Cell"},{"key":"BFnm3947_CR19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2007.03.048","volume":"129","author":"P Trojer","year":"2007","unstructured":"Trojer, P. et al. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 129, 915\u2013928 (2007).","journal-title":"Cell"},{"key":"BFnm3947_CR20","doi-asserted-by":"crossref","first-page":"27767","DOI":"10.1074\/jbc.M110.115410","volume":"285","author":"J Qin","year":"2010","unstructured":"Qin, J. et al. Chromatin protein L3MBTL1 is dispensable for development and tumor suppression in mice. J. Biol. Chem. 285, 27767\u201327775 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnm3947_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin, R.D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42, 181\u2013185 (2010).","journal-title":"Nat. Genet."},{"key":"BFnm3947_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin, R.D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298\u2013303 (2011).","journal-title":"Nature"},{"key":"BFnm3947_CR23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43, 830\u2013837 (2011).","journal-title":"Nat. Genet."},{"key":"BFnm3947_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","volume":"492","author":"MT McCabe","year":"2012","unstructured":"McCabe, M.T. et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108\u2013112 (2012).","journal-title":"Nature"},{"key":"BFnm3947_CR25","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","volume":"110","author":"SK Knutson","year":"2013","unstructured":"Knutson, S.K. et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc. Natl. Acad. Sci. USA 110, 7922\u20137927 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3947_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/neuonc\/nos285","volume":"15","author":"I Alimova","year":"2013","unstructured":"Alimova, I. et al. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells. Neuro-oncol. 15, 149\u2013160 (2013).","journal-title":"Neuro-oncol."},{"key":"BFnm3947_CR27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","volume":"18","author":"BG Wilson","year":"2010","unstructured":"Wilson, B.G. et al. Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation. Cancer Cell 18, 316\u2013328 (2010).","journal-title":"Cancer Cell"},{"key":"BFnm3947_CR28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10163","volume":"474","author":"WC Skarnes","year":"2011","unstructured":"Skarnes, W.C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337\u2013342 (2011).","journal-title":"Nature"},{"key":"BFnm3947_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","volume":"4","author":"IH Su","year":"2003","unstructured":"Su, I.H. et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nature immunology 4, 124\u2013131 (2003).","journal-title":"Nature immunology"},{"key":"BFnm3947_CR30","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv:1303.3997v1 [q-bio.GN] (2013)."},{"key":"BFnm3947_CR31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"BFnm3947_CR32","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/annonc\/mdu127","volume":"25","author":"MB Suraokar","year":"2014","unstructured":"Suraokar, M.B. et al. Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications. Ann. Oncol. 25, 1184\u20131192 (2014).","journal-title":"Ann. Oncol."},{"key":"BFnm3947_CR33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nprot.2007.106","volume":"2","author":"BA Garcia","year":"2007","unstructured":"Garcia, B.A. et al. Chemical derivatization of histones for facilitated analysis by mass spectrometry. Nat. Protoc. 2, 933\u2013938 (2007).","journal-title":"Nat. Protoc."},{"key":"BFnm3947_CR34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968 (2010).","journal-title":"Bioinformatics"},{"key":"BFnm3947_CR35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","volume":"14","author":"AV Krivtsov","year":"2008","unstructured":"Krivtsov, A.V. et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14, 355\u2013368 (2008).","journal-title":"Cancer Cell"},{"key":"BFnm3947_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-61779-316-5_20","volume":"791","author":"H O'Geen","year":"2011","unstructured":"O'Geen, H., Echipare, L. & Farnham, P.J. Using ChIP-seq technology to generate high-resolution profiles of histone modifications. Methods Mol. Biol. 791, 265\u2013286 (2011).","journal-title":"Methods Mol. Biol."},{"key":"BFnm3947_CR37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"BFnm3947_CR38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A.R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"BFnm3947_CR39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W B\u00e9guelin","year":"2013","unstructured":"B\u00e9guelin, W. et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23, 677\u2013692 (2013).","journal-title":"Cancer Cell"},{"key":"BFnm3947_CR40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-Determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"BFnm3947_CR41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7150\/jca.2.507","volume":"2","author":"YT Phung","year":"2011","unstructured":"Phung, Y.T., Barbone, D., Broaddus, V.C. & Ho, M. Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy. J. Cancer 2, 507\u2013514 (2011).","journal-title":"J. Cancer"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3947.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3947","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3947.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:52:48Z","timestamp":1684450368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFnm3947"],"URL":"https:\/\/doi.org\/10.1038\/nm.3947","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,5]]},"assertion":[{"value":"14 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.K.K., J.E.C. and H.K. are employees of Epizyme, Inc. S.A.A. is a consultant for Epizyme, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}